In this webinar, Colin Edgerton, Executive Chairman of American Rheumatology Network and Mary Jo Carden, Head of Policy at Sandoz Inc. will discuss the clinical and policy issues surrounding the future success of biosimilars in the pharmacy benefit.
Speakers:
- Colin Edgerton, MD
Executive Chairman
American Rheumatology Network - Mary Jo Carden, RPh, JD
Head of Policy
Sandoz Inc.
** IMPORTANT: AMCP webinars are limited to the first 1000 that join the webinar. However, AMCP will provide a link to the recording and slides to all registrants within a week from the webinar date. The recording and slides of sponsored webinars will be provided if permitted by the sponsor.
Click here for additional information and registration details.
Related Content
Evidence Matters 2022
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.